However, FAT4 mutation was no longer associated with better PFS or OS in the young subgroup (Fig. 3A and Figure S1 E–F), suggesting the existence of differences in genetic characteristics or carcinogenesis between old and young DLBCL patients. This evidence concerns the gene FAT4 and diffuse large B-cell lymphoma.